We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over 1 million patient test cases analyzed and interpreted.
Supporting more than 1,000 clinical laboratories and physicians worldwide, the cloud-based QCI platform provides all of the capabilities required to transform complex data from next-generation sequencing (NGS) into actionable insights. The two platform components—QCI Analyze and QCI Interpret—simplify and streamline variant analysis and interpretation, yielding standardized, evidence-based reports with actionable information.
“Surpassing 1 million patient test cases is strong validation for QCI. Over 1,000 customers worldwide have processed patient tests, ranging from targeted panels to whole exome or genome results across multiple indications, germline to somatic cancer, to gain actionable insights from the QIAGEN Knowledge Base.”Dr. Jonathan Sheldon, Senior Vice President, QIAGEN Bioinformatics
When a genetic testing lab runs NGS data through QCI, the software computes variant classifications according to guidelines set by industry experts, such as ACMG, AMP, ASCO, and CAP. QCI bases variant classifications on the evidence obtained from multiple sources, including full-text articles and public and private databases, all of which are contained within the QIAGEN Knowledge Base.
“This knowledge base is the industry’s most expansive collection of expert-curated biological and clinical findings built from over 20 years of manual data and literature curation, enabling deep clinical insights across a broad range of disease indications,” says Sheldon. “While handling 1 million patient cases is a monumental milestone, this is just the beginning. We are now supporting large-scale programs for precision medicine like Genomics England and the National Cancer Center Japan and are seeing the realization of our goal of using bioinformatics to make improvements in life possible.”
The cloud-based QCI software delivers insights to clinical laboratories and physicians in North America, Europe and the Asia-Pacific region, enabling and advancing the practice of precision medicine.
To learn more about QCI and how the platform is advancing precision medicine, visit our clinical solutions web page.
© QIAGEN 2019. All rights reserved - Trademarks & Disclaimers